Marco Cattalini, Marco Cattalini, Jessica Galli, Jessica Galli, Fiammetta Zunica, Rosalba Monica Ferraro, . . . Raffaele Badolato. (2021). Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation. Frontiers Media S.A..
Chicago Style (17th ed.) CitationMarco Cattalini, et al. Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationMarco Cattalini, et al. Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation. Frontiers Media S.A., 2021.
Warning: These citations may not always be 100% accurate.